[12/12/06]
In a letter to VeriChip Corporation, a subsidiary of Applied Digital Solutions, the National Stroke Association (NSA) has recognized that implantable RFID microchip technology offers the ability to improve stroke treatment by providing medical professionals with immediate access to vital health information of stroke-afflicted patients. An excerpt from the letter, signed by James Baranski, CEO of the National Stroke Association, states, "Personal Health Records, including implantable RFID microchips such as VeriMed, could play a critical role in assisting medical professionals in delivering appropriate stroke treatment promptly, leading to better patient outcomes."
The VeriMed Patient Identification System which consists of a handheld RFID scanner, an implantable RFID microchip and a secure patient database, is being used to help rapidly identify and provide access to important health information on participating patients who arrive at an emergency department unconscious, delirious or unable to communicate. This implantable RFID system is the only system of its type cleared by the United States Food and Drug Administration for use in people.
The National Stroke Association is the only national organization in the United States that focuses 100% of its efforts on stroke. Established in 1984, the NSA has become a leading national resource on stroke and the driving force behind efforts to improve stroke prevention, treatment and rehabilitation.
About NSA:
National Stroke Association is the leading national non-profit organization devoting all of its efforts and resources to stroke. NSA provides the most up-to-date information on prevention, treatment, rehabilitation and support for stroke survivors and their families. For more information on NSA and our programs please contact 1-800-STROKES or visit http://www.stroke.org.
About VeriChip Corporation:
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed Patient Identification System which is used to rapidly and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human- implantable passive RFID microchip, the implantable VeriChip, cleared for medical use in October 2004 by the United States Food and Drug Administration.
|
